AirNet Technology raises $180 million in digital assets offering
NEW YORK - DocGo Inc. (NASDAQ:DCGO), a mobile healthcare provider currently trading at $1.42 per share, has secured a new contract to provide community vaccination services for The County of San Diego, California, the company announced Thursday.
The program aims to expand healthcare access for underserved populations in San Diego’s East and North-Central neighborhoods. Vaccinations will be offered at various locations including schools, houses of worship, public parks, neighborhood centers, and in-home settings.
Under the agreement, DocGo will coordinate with county officials, community organizations, and trusted agencies to promote program awareness with a focus on improving immunization equity across populations disproportionately impacted by infectious disease.
"We look forward to providing both health education and the vaccines that can help children and adults thrive, helping improve neighborhood health," said Lee Bienstock, CEO of DocGo.
This marks DocGo’s first contract with San Diego County, though the company already provides mobile health services for insurance payers in the area. The program will ensure individuals who are disabled, frail, or lack transportation access can receive vaccination treatments.
DocGo, which trades on the Nasdaq, describes itself as a provider of technology-enabled mobile health and medical transportation services. The company utilizes a care delivery platform that includes mobile health services, remote patient monitoring, and ambulance services.
The information in this article is based on a company press release statement.
In other recent news, DocGo Inc. reported its first-quarter 2025 earnings, which fell short of expectations. The company announced an earnings per share (EPS) of -$0.09, missing the expected $0.02, and revenue of $96 million, which was below the forecasted $111.93 million. Additionally, DocGo revised its 2025 revenue guidance from $410-$450 million to $300-$330 million, citing challenges in the municipal channel due to policy changes and budgetary constraints. This update suggests a potential 50% year-over-year decline in revenue. Following these developments, BTIG downgraded DocGo’s stock from Buy to Neutral, noting the company’s adjusted EBITDA loss of $3.9 million, which was significantly below expectations.
In other corporate news, DocGo’s subsidiary, Ambulnz, secured a $3.4 million contract with the Albany Stratton VA Medical Center for medical transportation services. This contract, which started on July 1, includes providing basic life support, advanced life support, and critical care ambulance services. Additionally, DocGo’s recent Annual Meeting of Stockholders resulted in the election of three Class I directors, with Lee Bienstock, Ely D. Tendler, and Ira Smedra receiving the majority of votes. These developments reflect ongoing changes and challenges for DocGo as it navigates the current fiscal year.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.